Quality assessment for non-randomized trials | Thompson, GH | Sponseller, PD | Bess, S | Uzumcugil, O | Zhao, Y | Akgul, T |
---|---|---|---|---|---|---|
A clearly stated aim | 2 | 2 | 2 | 2 | 2 | 2 |
Inclusion of consecutive patients | 2 | 2 | 2 | 1 | 1 | 1 |
Prospective data collection | 0 | 0 | 1 | 0 | 2 | 2 |
End points appropriate to the aim of the study | 2 | 0 | 2 | 2 | 2 | 2 |
Unbiased assessment of the study end point | 0 | 0 | 0 | 0 | 0 | 0 |
A follow-up period appropriate to the aims of the study | 2 | 2 | 2 | 2 | 2 | 2 |
Less than 5 % loss to follow-up | 0 | 2 | 2 | 2 | 2 | 2 |
Prospective calculation of the sample size | 0 | 0 | 0 | 0 | 0 | 0 |
An adequate control group | 2 | 2 | 2 | 2 | 2 | 2 |
Contemporary groups | 2 | 2 | 2 | 2 | 2 | 2 |
Baseline equivalence of groups | 2 | 1 | 1 | 2 | 2 | 2 |
Adequate statistical analyses | 2 | 0 | 2 | 2 | 2 | 2 |